These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22387005

  • 1. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K, Toyooka S, Ichimura K, Soh J, Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, Tsukuda K, Yamane M, Oto T, Kiura K, Miyoshi S.
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [Abstract] [Full Text] [Related]

  • 2. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R, Korourian A, Shariftabrizi A, Madjd Z.
    Cancer Invest; 2015 Jul; 33(7):294-302. PubMed ID: 26046383
    [Abstract] [Full Text] [Related]

  • 3. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N, Choung HK, Lee MJ, Khwarg SI, Kim JE.
    Invest Ophthalmol Vis Sci; 2015 Feb 24; 56(3):1813-9. PubMed ID: 25711631
    [Abstract] [Full Text] [Related]

  • 4. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C, Xu Y, Li X, Ren S, Zhao C, Hou L, Ye Z, Zhou C.
    Int J Clin Exp Pathol; 2015 Feb 24; 8(5):5509-18. PubMed ID: 26191258
    [Abstract] [Full Text] [Related]

  • 5. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
    Herpel E, Jensen K, Muley T, Warth A, Schnabel PA, Meister M, Herth FJ, Dienemann H, Thomas M, Gottschling S.
    Anticancer Res; 2011 Dec 24; 31(12):4491-500. PubMed ID: 22199321
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP).
    Gottschling S, Herpel E, Eberhardt WE, Heigener DF, Fischer JR, Köhne CH, Kortsik C, Kuhnt T, Muley T, Meister M, Bischoff HG, Klein P, Moldenhauer I, Schnabel PA, Thomas M, Penzel R.
    Lung Cancer; 2012 Jul 24; 77(1):183-91. PubMed ID: 22483783
    [Abstract] [Full Text] [Related]

  • 9. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
    Li F, Zeng H, Ying K.
    Med Oncol; 2011 Dec 24; 28(4):1458-62. PubMed ID: 20717756
    [Abstract] [Full Text] [Related]

  • 10. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W.
    Pathol Int; 2012 Feb 24; 62(2):112-9. PubMed ID: 22243781
    [Abstract] [Full Text] [Related]

  • 11. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L, Galetta D, Spaggiari L, Schmid RA, Karoubi G.
    Eur J Cardiothorac Surg; 2012 Jun 24; 41(6):e173-81. PubMed ID: 22529186
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
    Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, Matsuno Y, Taketomi A.
    BMC Cancer; 2014 Sep 21; 14():687. PubMed ID: 25240521
    [Abstract] [Full Text] [Related]

  • 13. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.
    Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294
    [Abstract] [Full Text] [Related]

  • 14. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu LQ, Zhou ZT.
    Int J Cancer; 2013 Feb 15; 132(4):868-74. PubMed ID: 22782852
    [Abstract] [Full Text] [Related]

  • 15. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y, He Y, Li H, Li HN, Zhang L, Hu W, Sun YM, Chen FL, Jin XM.
    Gastric Cancer; 2012 Oct 15; 15(4):440-50. PubMed ID: 22395309
    [Abstract] [Full Text] [Related]

  • 16. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis.
    Gottschling S, Jensen K, Warth A, Herth FJ, Thomas M, Schnabel PA, Herpel E.
    Eur Respir J; 2013 Mar 15; 41(3):656-63. PubMed ID: 22743677
    [Abstract] [Full Text] [Related]

  • 17. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
    Gottschling S, Jensen K, Herth FJ, Thomas M, Schnabel PA, Herpel E.
    Anticancer Res; 2013 Mar 15; 33(3):981-90. PubMed ID: 23482770
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
    Mansour SF, Atwa MM.
    Asian Pac J Cancer Prev; 2015 Mar 15; 16(17):7491-6. PubMed ID: 26625750
    [Abstract] [Full Text] [Related]

  • 19. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J, Toulany M, Bareiss PM, Grimm S, Lengerke C, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2011 Jun 15; 99(3):300-6. PubMed ID: 21704411
    [Abstract] [Full Text] [Related]

  • 20. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N, Bozkurt KK, Başpınar Ş, Koçer M, Eroğlu HE, Akdeniz R, Akçil M.
    Pathol Res Pract; 2015 Oct 15; 211(10):740-7. PubMed ID: 26298632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.